A Portable Device for Rapid and Highly Sensitive Diagnostics

When remote regions with limited health facilities experience an epidemic, they need portable diagnostic equipment that functions outside the hospital. As demand for such equipment grows, EPFL researchers have developed a low-cost and portable microfluidic diagnostic device. It has been tested on Ebola and can be used to detect many other diseases.

Over the past several years, microfluidic devices have shown extraordinary potential in the area of diagnostics. They are composed of silicone rubber with minuscule channels the width of a hair. Microfluidic devices, and can rapidly detect a number of different biomarkers in very small quantities of blood.

At EPFL, a new type of microfluidic platform has come out of the Laboratory of Biological Network Characterization (LBNC), headed by Sebastian Maerkl. It is a portable device that runs on battery power and is completely self-sustained. It operates seamlessly with inexpensive microscopes and provides very high levels of accuracy and detection. The platform, which is described in a recent ACS Nano article, can quantify up to 16 different molecules - or biomarkers - in a tiny amount of blood (less than 0.005 milliliters). The biomarkers are usually enzymes, proteins, hormones or metabolites and the concentration of these molecules in the blood provides precise information on the patient's health condition.

Two detection readouts in one platform
The device is unique in that it is composed of both analog and digital detection mechanisms, while conventional devices hitherto only integrated one or the other. Digital detection is highly sensitive and can detect the presence of a single biomarker. However, it is less effective when the concentration of biomarkers is too high, due to signal saturation. Analog measurements, on the other hand, function best at higher biomarker concentrations. Using these two detection mechanisms simultaneously, the composition of a drop of blood can be thoroughly analyzed in a short amount of time. The analysis provides precious medical information: it could help doctors make an early diagnosis or determine the stage of a disease.

Initial testing has been successfully carried out on a sample containing anti-Ebola antibodies, which indicate the presence of the virus in both symptomatic and asymptomatic patients. The device could potentially work with a large number of other protein biomarkers and molecules.

No need to pre-treat blood samples
There is more good news. Researchers at EPFL found that they could load the blood sample directly onto the device and perform on-chip biomarker quantitation without requiring any sample pre-treatment. "For researchers, it is quite interesting to be able to avoid having to separate the blood," said Francesco Piraino, the article's lead author. Blood plasma separation requires centrifuges, large volume samples and a long processing time.

For diagnoses in resource-limited regions
Says Piraino: "The platform will lead the development of new kinds of tests to meet the increasing demand for on-site diagnostic testing. It will prove very useful for medical staff working in resource-limited regions." The device could, for example, be used to monitor endemic, epidemic, and pandemic disease outbreaks.

Francesco Piraino, Francesca Volpetti, Craig Watson, and Sebastian J. Maerkl
A Digital-Analog Microfluidic Platform for Patient-Centric Multiplexed Biomarker Diagnostics of Ultralow Volume Samples
ACS Nano 2016 10 (1), 1699-1710, DOI: 10.1021/acsnano.5b07939

Most Popular Now

EyeFocus Eye Care Innovation Conference

31 January 2017, London, UK. EyeFocus is holding a one day conference about eye-care innovation to end the second EyeFocus program. The conference is instead of the traditional demo day, and...

Read more

New Virtual Reality Technology may Impro…

A combination of traditional physical therapy and technology may improve the motor skills and mobility of an impaired hand by having its partner, more mobile hand lead by example through...

Read more

European Commission Seeks Input on a Ref…

Smart wearables provide technology-based solutions to pressing societal and economic challenges in the areas of healthy ageing, elderly care, emergency management, safety at work, productivity enhancement, training of professionals, energy...

Read more

Top 20 eHealth News of 2016

Look back at the most prominent moments from the year 2016. We are proud to announce the 20 most popular eHealth News from 2016, the most commonly viewed news articles...

Read more

conhIT Newcomer Awards 2017: Health IT I…

25 - 27 April 2017, Berlin, Germany. By bringing representatives of the Health IT industry and other Healthcare institutions together with prospective young employees conhIT 2017, Europe's leading event for Health...

Read more

Philips and Leading Network of Healthcar…

Royal Philips (NYSE: PHG, AEX: PHIA) today announced the signing of a 10-year strategic partnership agreement with the Expert Group of Companies, one of Russia's leading network of healthcare centers...

Read more

Ireland's First Babies Born with an Elec…

The HSE and eHealth Ireland are delighted to announce the arrival of Emily, one of Ireland’s first newborns to have their own electronic health record from birth. Weighing 7lb 5oz...

Read more

MSD Innovation Factory: SMART STOCK Chal…

Pharmacy Chains in the EEMEA Region are growing rapidly. These are in the range of 150+ pharmacy outlets or so called PoS (Point of Sale). Thousands of prescriptions are being...

Read more

Dudley Group Adds Allscripts SunriseTM E…

In the fourth quarter of 2016, The Dudley Group NHS Foundation Trust selected Allscripts (NASDAQ:MDRX) fully integrated health IT solution to help achieve its objective to become a fully digital...

Read more

Philips Highlights Cloud-Based Innovatio…

Royal Philips (NYSE: PHG, AEX: PHIA) is showcasing innovative connected health products and solutions that empower consumers to become ever-more engaged in their health. Leveraging Philips' expertise in the consumer...

Read more

MSD Innovation Factory: INNOREP Challeng…

Nowadays, pharmaceutical launches are becoming harder and more competitive. In some cases, MSD products are neither the only nor the first player in the market. Besides, clinical data can be...

Read more

MSD Innovation Factory: EDU CARE Challen…

At healthcare professionals' waiting room around the globe there is a repeated scenario: inattentive patients spend their time before being seen by their healthcare professionals. Sometimes playing with their smartphones...

Read more
(HEALTH IT) SPACE - Take a look at who has just Joined